The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Long‐term corticosteriod treatment of myasthenia gravis: Report of 116 Patients
Abstract
One hundred sixteen patients, aged 8 to 82 years, with myasthenia gravis were treated with prednisone, 6o to 80 mg daily, until the onset of improvement, followed by lower‐dose alternate‐day therapy of several years' duration. Of all patients, 80.2%achived wither remission(27.6%) or marked improvement (52.6%). Moderate improvement occurred in 14.7%, and 5.2% showed no improvement. Increasing age correlated with a favorable outcome, but sex, duration of illness prior to treatment, severity and distribution of weaskness at the time of onset of treatment, and presence of thymoma were not factors in the response to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLA ANTIGENS AND SCHIZOPHRENIA
Mendlewicz, J., & Linkowski, P. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91256-8 · Cited by 302
Anti-acetylcholine receptor antibodies.
Vincent, A. C., & Davis, J. N. (1980) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.43.7.590 · Cited by 157
Benefit from Alternate-Day Prednisone in Myasthenia Gravis
Warmolts, J. R., & Engel, W. K. (1972) · New England Journal of Medicine · doi:10.1056/nejm197201062860104 · Cited by 126
Brunner, N. G., Namba, T., & Grob, D. (1972) · Neurology · doi:10.1212/wnl.22.6.603 · Cited by 74
Brunner, N. G., Berger, C. L., Namba, T., et al. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb47717.x · Cited by 61
Corticotropin in Generalized Myasthenia Gravis: Effect of Short, Intensive Courses
Grob, D. (1966) · JAMA · doi:10.1001/jama.198.7.703 · Cited by 49
Myasthenia gravis: A personal view of pathogenesis and mechanism, part 1
Simpson, J. A. (1978) · Muscle & Nerve · doi:10.1002/mus.880010107 · Cited by 37
Cited by
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Meriggioli, M. N., & Sanders, D. B. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70063-8 · Cited by 894
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
Guidelines for treatment of autoimmune neuromuscular transmission disorders
Skeie, G. O., Apostolski, S., Evoli, A., Gilhus, N. E., Illa, I., Harms, L., Hilton‐Jones, D., Melms, A., Verschuuren, J., & Horge, H. W. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03019.x · Cited by 515
Melzer, N., Ruck, T., Fuhr, P., Gold, R., Hohlfeld, R., Marx, A., Melms, A., Tackenberg, B., Schalke, B., Schneider-Gold, C., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8045-z · Cited by 292
Clinical evaluation and management of myasthenia gravis
Keesey, J. C. (2004) · Muscle & Nerve · doi:10.1002/mus.20030 · Cited by 285
Metadata
- Authors
- Pascuzzi, R. M., Coslett, H. B., & Johns, T. R.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1984-03
- Volume
- 15
- Issue
- 3
- Pages
- 291-298
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2168664900
- Cited by
- 333
- References
- 7
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.